Newsletter | July 29, 2026

07.29.26 -- Key Considerations for Combination Product Development

Novel Combination Drug Delivery Devices: Design And Development

Getting the problem definition right before development begins is the single biggest lever you have on program timelines and cost. Explore the “Phase 0” scoping framework that translates clinical needs into a structured project.

 

Mechanical Engineering Design Process For Combination Products

Converting user needs into manufacturable combination drug-delivery devices means converting qualitative requirements into precise mechanical specs, managing risk at the component level, and validating designs virtually before a single prototype is built. Read on to see how each engineering phase connects.

 

Key Considerations For Selecting Fill/Finish Manufacturing Technologies

Manufacturing planning is a critical step in the path to commercialization and helps companies accelerate their path to market. Obtaining information and proactively mapping out your fill/finish strategy early can de-risk an investment in equipment or processes, ensuring you meet your long-term needs.

 

De-Risk Your Combination Product Development

Relying on fragmented components for drug delivery systems creates unnecessary regulatory complexity and administrative delays. Consider how adopting a unified, pre-verified system streamlines performance testing and data management and can help to meet critical clinical milestones with greater speed.

 

Selecting A Prefillable Syringe System With Confidence

Prefilled syringe selection can stall drug development for months. The West Synchrony S1 PFS system integrates barrel, plunger, and needle shield from a single supplier, reducing complexity for emerging biotech. Review the full Q&A to see if it fits your program.

 

SOLUTIONS

Mitigating Risk With The Right Contract Manufacturing Partner

West Vantage delivers end-to-end contract manufacturing solutions for pharmaceutical, diagnostics, and medical device companies.

 

UPCOMING EVENT

 

 

Mark your calendar! Join West’s Richard Kieran at CPHI Milan to hear him present “Strategic CDMO Partnerships in Combination Drug–Device Development: Accelerating Time to Market While Mitigating Risks” on October 6 at 14:15 in the Packaging & Device Innovation Theatre. To schedule a meeting with West, please email meetwest@westpharma.com.